Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN1B anticorps (C-Term)

CDKN1B Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2792168
  • Antigène Voir toutes CDKN1B Anticorps
    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
    Épitope
    • 28
    • 28
    • 22
    • 19
    • 17
    • 16
    • 11
    • 10
    • 9
    • 8
    • 8
    • 8
    • 8
    • 8
    • 7
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 271
    • 126
    • 106
    • 26
    • 8
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 235
    • 49
    • 2
    • 1
    • 1
    Lapin
    Clonalité
    • 231
    • 57
    Polyclonal
    Conjugué
    • 138
    • 24
    • 17
    • 16
    • 16
    • 14
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp CDKN1B est non-conjugé
    Application
    • 198
    • 134
    • 72
    • 60
    • 51
    • 41
    • 31
    • 26
    • 21
    • 16
    • 16
    • 11
    • 7
    • 7
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Séquence
    EQCAGIRKRP ATDDSSTQNK RANRTEENVS DGSPNAGSVE QTPKKPGLRR
    Homologie
    Human: 100%
    Attributs du produit
    This is a rabbit polyclonal antibody against CDKN1B. It was validated on Western Blot using a cell lysate as a positive control.
    Purification
    Affinity Purified
    Immunogène
    The immunogen is a synthetic peptide directed towards the C terminal region of human CDKN1B
    Top Product
    Discover our top product CDKN1B Anticorps primaire
  • Indications d'application
    Optimal working dilutions should be determined experimentally by the investigator.
    Commentaires

    Antigen size: 198 AA

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Azzato, Driver, Lesueur, Shah, Greenberg, Easton, Teschendorff, Caldas, Caporaso, Pharoah: "Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort." dans: Breast cancer research : BCR, Vol. 10, Issue 3, pp. R47, (2008) (PubMed).

  • Antigène
    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
    Autre désignation
    CDKN1B (CDKN1B Produits)
    Synonymes
    anticorps CDKN4, anticorps KIP1, anticorps MEN1B, anticorps MEN4, anticorps P27KIP1, anticorps cdkn1b, anticorps sb:cb611, anticorps wu:fb63g10, anticorps wu:fb64g10, anticorps wu:fe18e03, anticorps CDKN1B, anticorps Kip1, anticorps p27, anticorps FAM14D, anticorps ISG12, anticorps ISG12A, anticorps P27, anticorps Cdki1b, anticorps AA408329, anticorps AI843786, anticorps p27Kip1, anticorps cdkn1bl, anticorps cyclin dependent kinase inhibitor 1B, anticorps cyclin-dependent kinase inhibitor 1Bb, anticorps interferon alpha inducible protein 27, anticorps cyclin-dependent kinase inhibitor 1B, anticorps cyclin-dependent kinase inhibitor 1Ba, anticorps CDKN1B, anticorps cdkn1bb, anticorps IFI27, anticorps Cdkn1b, anticorps cdkn1ba
    Sujet
    CDKN1B is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. It binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state.This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
    Alias Symbols: CDKN4, KIP1, MEN1B, MEN4, P27KIP1
    Protein Interaction Partner: CCND1, UBC, SGK1, PSMB1, CDK4, SKP2, CDK5, CDK3, CDK2, CDK1, SKP1, CKS1B, CCNE1, CCND3, CAMK1, YWHAQ, CCNA2, ABL1, TSC2, LYN, STMN1, RHOA, RPS6KA1, IRF1, KPNA6, CCNE2, CCNA1, VCP, SRC, MAPK10, MAPK8, CDC34, CDK6, RCHY1, COPS5, CUL1, HIST1H1A, CUL4A, JAK2,
    Protein Size: 198
    Poids moléculaire
    22 kDa
    ID gène
    1027
    NCBI Accession
    NM_004064, NP_004055
    UniProt
    P46527
    Pathways
    Cycle Cellulaire, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Sensory Perception of Sound, Mitotic G1-G1/S Phases, DNA Replication, Positive Regulation of Endopeptidase Activity, Synthesis of DNA, Autophagy
Vous êtes ici:
Support technique